Lucid Diagnostics Inc (LUCD) Live Share Price, Invest From India

Lucid Diagnostics Inc Stock Performance

as on May 13, 2026 at 6:59 am IST

Day's Low
Day's High
$1.01
Day's Price Range
$1.07
$1.04
2.88%
Downside
2.88%
Upside
52 Week's Low
52 Week's High
$0.95
52-Week Price Range
$1.70
$1.04
8.70%
Downside
63.46%
Upside

Lucid Diagnostics Inc share price movements today

Previous Close: $1.02
Open: $1.03
Volume: 949.9K
Day's Low - High: $1.01 - $1.07
52 Week Low - High: $0.95 - $1.70

Lucid Diagnostics Inc Historical Returns

1 Month Return: -11.3 %
3 Month Return: -16.39 %
1 Year Return: -7.27 %
3 Year Return: -33.33 %
5 Year Return: 0 %

Lucid Diagnostics Inc Stock Fundamentals & Key Indicators

Check Lucid Diagnostics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$201.1M

EPS (TTM)

-0.23

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-48.8M

Revenue (TTM)

4.7M

Profit Margin

0.00%

Return On Equity TTM

-710.60%

Lucid Diagnostics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lucid Diagnostics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lucid Diagnostics Inc	BUY	$201.1M	NA	NA	0.00%
Boston Scientific Corp	BUY	$80.2B	29.07%	22.56	17.29%
Stryker Corporation	BUY	$109.3B	15.45%	33	13.21%
Edwards Lifesciences Corp	BUY	$44.4B	-11.78%	41.71	17.39%
Medtronic PLC	BUY	$97.8B	-39.46%	21.27	13.00%

See all

Stock Returns calculator for Lucid Diagnostics Inc Stock including INR - Dollar returns

The Lucid Diagnostics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Lucid Diagnostics Inc investment value today

Current value as on today

₹1,06,501

Returns

₹6,501

(+6.5%)

Returns from Lucid Diagnostics Inc Stock

-₹5,455 (-5.45%)

Dollar Impact

₹11,955 (+11.96%)

Analyst Recommendation on Lucid Diagnostics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Lucid Diagnostics Inc. Average target price of $4.1

Lucid Diagnostics Inc Share Price Target

Get share price movements and forecasts by analysts on Lucid Diagnostics Inc.

What analysts predicted

74.63%UPSIDE

Target Price

$4.1

Current Price

$1.04

Analyzed by

12 Analysts

Target

$4.10

Lucid Diagnostics Inc target price $4.1, a slight upside of 74.63% compared to current price of $1.04. According to 12 analysts rating.

Indian Investors' Interest in Lucid Diagnostics Inc Stock

Search interest for Lucid Diagnostics Inc Stock has increased by 115% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:115% versus previous 30 day period

Lucid Diagnostics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	1	1	0	1	1	0	1	1	1
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-11	-11	-10	-11	-11	-12	-12	-11	-11	-14
EBITDA	-13	-10	-10	-10	-12	-11	-26	-4	-11	-13
Interest Expense	0	0	0	0	0	0	0	0	2	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-10	-10	-11	-12	-11	-26	-4	-10	-16
Income Tax Expense	-2	-1,960	7,496	-	-12,358	7,496	9,110	3,449	-	-
Net Income	-14	-10	-10	-11	-12	-11	-26	-4	-10	-16
Net Profit Margin	-1814.56%	-1041.35%	-1060.14%	-1127.56%	-1055.55%	-964.16%	-3249.76%	-381.69%	-858.55%	-1081.52%

Lucid Diagnostics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	0	0	2	4	4
Gross Profit	-	-	0	-3	-6	-3	-2
Operating Income	-4	-8	-27	-56	-48	-46	-49
EBITDA	-4	-8	-27	-54	-49	-44	-48
Interest Expense	-	-	0	0	0	0	0
Depreciation	-	-	0	1	2	1	0
Income Before Tax	-4	-8	-28	-56	-52	-45	-58
Income Tax Expense	-4	-8	0	1	2	7,496	12,559
Net Income	-4	-8	-28	-56	-52	-45	-58
Net Profit Margin	0.00%	0.00%	-5615.60%	-14899.47%	-2169.11%	-1047.61%	-1232.68%

Lucid Diagnostics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-10	-10	-11	-12	-11	-26	-4	-10	-26,652
Operating Cash Flow	-9	-12	-11	-10	-9	-12	-10	-10	-12
Investing Cash Flow	0	0	-	0	0	0	0	0	0
Financing Cash Flow	5	18	11	0	17	15	16	27	0
Change in Cash	-5	5	0	-10	7	2	5	16	-12

Lucid Diagnostics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-4	-8	-28	-56	-52	-45	-58,010
Operating Cash Flow	-2	-5	-17	-29	-32	-44	-46,485
Investing Cash Flow	0	0	0	-4	0	0	-197
Financing Cash Flow	2	5	72	2	29	48	59,029
Change in Cash	0	0	53	-31	-3	3	12,347

Global Institutional Holdings in Lucid Diagnostics Inc

Funds	Holdings
Vanguard Group Inc	2.63%
Aberdeen Group PLC	1.93%
Alyeska Investment Group, L.P.	0.72%
Perkins Capital Management Inc	0.6%
Renaissance Technologies Corp	0.44%

See all

Insights on Lucid Diagnostics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 828.0K → 1.50M (in $), with an average increase of 17.4% per quarter
NO EFFECT
Against Peers
In the last 3 years, LUCID DIAGNOSTICS INC. has experienced a drawdown of -33.3%, however Boston Scientific Corp. resisted the overall trend and outperformed by 19.8%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 2.2% return, outperforming this stock by 16.5%
NEGATIVE IMPACT
Price Dip
In the last 1 month, LUCD stock has moved down by -20.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -4.43M → -16.26M (in $), with an average decrease of 95.3% per quarter

About Lucid Diagnostics Inc

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Organisation	Lucid Diagnostics Inc
Headquarters	360 Madison Avenue, New York, NY, United States, 10017
Industry	Medical Devices
CEO	Dr. Lishan Aklog M.D.
E-voting on shares	Click here to vote

Key Management of Lucid Diagnostics Inc

Name	Title
Dr. Lishan Aklog M.D.	Chairman & CEO
Mr. Michael Adam Gordon	General Counsel & Secretary
Dr. Joseph Willis M.D.	Co-founder & Strategic Advisor
Dr. Brian J. deGuzman M.D.	Chief Technology & Compliance Officer
Mr. Matthew Riley	Director of Investor Relations
Mr. Shaun M. O'Neill M.B.A.	President & COO
Dr. Sanford D. Markowitz M.D., Ph.D.	Co-Founder & Strategic Advisor
Dr. Amitabh Chak M.D.	Co-Founder & Strategic Advisor
Helen Moinova Ph.D.	Co-Founder & Strategic Advisor
Dr. Suman M. Verma M.D., Ph.D.	Senior VP & Chief Scientific Officer

FAQs

What is Lucid Diagnostics Inc share price today?

Lucid Diagnostics Inc share price today is $1.04 as on May 13, 2026 at 1:29 am IST at the close of the market. Lucid Diagnostics Inc share today touched a day high of $1.07 and a low of $1.01.

What is the 52 week high and 52 week low for Lucid Diagnostics Inc share?

Lucid Diagnostics Inc share touched a 52 week high of $1.7 on May 27, 2025 and a 52 week low of $0.95 on August 1, 2025. Lucid Diagnostics Inc stock price today i.e. May 13, 2026 at 1:29 am IST is closed at $1.04,which is 38.82% down from its 52 week high and 9.53% up from its 52 week low.

What is Lucid Diagnostics Inc's market capitalisation today?

Lucid Diagnostics Inc market capitalisation is $0.00T as on May 13, 2026 at 1:29 am IST.

How to invest in Lucid Diagnostics Inc Stock (LUCD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lucid Diagnostics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lucid Diagnostics Inc Shares that will get you 1.4423 shares as per Lucid Diagnostics Inc share price of $1.04 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Lucid Diagnostics Inc Stock (LUCD) from India?

Indian investors can start investing in Lucid Diagnostics Inc (LUCD) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Lucid Diagnostics Inc stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:37 am IST). Based on Lucid Diagnostics Inc share’s latest price of $1.04 as on May 13, 2026 at 1:29 am IST, you will get 9.6154 shares of Lucid Diagnostics Inc. Learn more about fractional shares .